In a pivotal move to confront the growing threat of antimicrobial resistance (AMR), a global issue that renders infections increasingly difficult or impossible to treat, the UK Government has announced a substantial funding package of up to £85 million.
This commitment was unveiled during a high-level event, “The World Together Solving the Antibiotic Emergency,” organized by the government in partnership with The Royal Society.
The event brought together world leaders, experts, and survivors of AMR to underscore the urgency of the situation and agree on priority actions. His Royal Highness The Prince of Wales and the Chancellor of the Exchequer, Jeremy Hunt, were among the notable attendees, underscoring the gravity of the crisis at hand.
A Multifaceted Approach
The funding package encompasses several initiatives aimed at tackling AMR from multiple angles:
- Up to £50 million will be allocated to partnering with countries in Africa to improve access to essential antimicrobial drugs, building on the ongoing work of the UK Global AMR Innovation Fund.
- Up to £25 million will be directed towards strengthening surveillance systems for AMR in the Caribbean region, enabling accurate monitoring of threats and identification of outbreaks before they develop.
- Up to £10 million will be dedicated to establishing a Global Independent Scientific Panel for AMR, modeled after the renowned International Panel on Climate Change, in a matched funding partnership with the Kingdom of Saudi Arabia.
Key Initiatives |
|
|---|---|
| African Partnerships | Up to £50M for improved access to antimicrobial drugs |
| Caribbean Surveillance | Up to £25M for strengthening AMR monitoring systems |
| Global Scientific Panel | Up to £10M for coordinated international action |
Escalating Costs and Consequences
The urgency of addressing AMR is underscored by staggering statistics. In 2019, an estimated 4.95 million global deaths were associated with drug-resistant bacterial infections, and by 2050, this figure is projected to rise to 10 million. The economic toll is equally alarming, with the global cost of AMR estimated to reach 100 trillion US dollars.
“Antimicrobial Resistance could render our most vital medicines useless – it is a threat the world must take extremely seriously,”
warned Health Minister Stephenson.
“This package of up to £85 million builds on the world-leading work the UK government is already doing to support low- and middle-income countries to monitor, research and tackle this disease.”
A Concerted Global Effort
The UK’s initiatives align with broader international efforts to combat AMR through a coordinated, multisectoral approach. The World Health Organization, Food and Agriculture Organization (FAO), and World Organisation for Animal Health (OIE) have formed a Tripartite to promote responsible antimicrobial use across humans, animals, and plants through a One Health approach.
The Interagency Coordination Group on AMR has recommended actions in five key areas: country progress, innovation, collaboration, financing, and governance to address AMR globally. The World Health Organization is supporting countries to develop and implement national action plans, enhance surveillance, and improve antimicrobial stewardship.
Better Tracking
Furthermore, the US Centers for Disease Control and Prevention (CDC) is collaborating with countries to build capacity for AMR tracking, infection prevention, antibiotic stewardship, and implementing national action plans through initiatives like the AMR Challenge.
These global efforts aim to improve access to antimicrobials, strengthen surveillance, promote responsible use, enhance infection prevention and control, and foster international collaboration and financing to combat this major public health threat.
A Call for Global Collaboration
UK Special Envoy on AMR, Dame Sally Davies, emphasized the existential nature of the threat and the need for collective action.
“The global antibiotic emergency is an existential threat to communities everywhere,” she said. “I call on everyone to join us to make equity, One Health and action the cornerstone of our next steps to tackle AMR.”
The Foreign Secretary, Lord Cameron, echoed this sentiment, stating,
“Today antimicrobial resistance is a global emergency posing a vast threat to our health, our development, and our security. We must do more to tackle this threat and do it together, because it is too big to tackle without united global action.”
Ongoing Efforts and Future Steps
The UK’s commitment to addressing AMR is not new. In addition to the recently announced £210 million partnership with countries across Asia and Africa through the Fleming Fund, the government has also invested £1.8 million in creating a dedicated team within the Medical Healthcare products Regulatory Authority (MHRA) to support the development of novel antimicrobials and diagnostics.
Looking ahead, the event served as a crucial milestone in the lead-up to the United Nations High-Level Meeting on AMR in September, where further commitments and actions are expected to be discussed on the global stage.
Sources: THX News, Department of Health and Social Care, HM Treasury, Medicines and Healthcare products Regulatory Agency, Foreign, Commonwealth and Development Office, UK Health Security Agency, .
